Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Diagnostics channel feed
Illumina confirms SEC has closed investigation into $8B Grail deal
2 days ago
Pharma
Illumina forecasts $85M in tariff costs, decrease in China sales
2 days ago
Pharma
Exclusive: SEC expected to drop investigation of Illumina's $8B Grail deal
4 days ago
Deals
Law
GeneDx to buy Fabric Genomics for up to $51M
4 weeks ago
Deals
Revvity secures $37.8M contract to help screen UK newborns for rare diseases
Last month
Illumina adds activist investor to board, taps former FDA head as chair
Last month
People
Illumina was built on DNA. Its future could be biology’s next big wave
Last month
In Focus
China bans imports of Illumina's DNA sequencers following US tariffs
2 months ago
China
Roche no longer wants to be where ‘DNA sequencing goes to die’
2 months ago
R&D
Former FDA chief calls job cuts ‘haphazard, poorly thought-out’
2 months ago
Pharma
Post-Hoc: China tensions both help and hurt Illumina
3 months ago
China
Lantheus to buy Life Molecular Imaging for $350M, netting Alzheimer's diagnostic
3 months ago
Deals
Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra
4 months ago
Deals
Tracer Biotechnologies raises $10M, partners with AstraZeneca
4 months ago
Deals
Pleno raises $25M for multiomics testing, names new CEO
4 months ago
Illumina seeks to dismiss shareholder lawsuit, denies secret $800M stake
5 months ago
Law
PrognomiQ raises $34M for lung cancer test
6 months ago
Deals
Atlas of tumors reveals in 3D how cells change into cancer
6 months ago
R&D
Discovery
PacBio bets on 'inflection point' with $500 long-read genome
6 months ago
R&D
Illumina's pitch for new machines: You, too, can sequence DNA
7 months ago
Court's ruling on Illumina-Grail deal could signal a limit to European antitrust powers
8 months ago
Deals
Pharma
Illumina wins FDA approval for test to identify treatable cancers
8 months ago
FDA+
In bid to save cash, Grail says it will cut 350 jobs and focus on multi-cancer test
8 months ago
To get back to growth, Illumina CEO says it's simplifying DNA sequencing and analysis
8 months ago
1
2
3
4
Next page
Last page